Rate My Professor Chris Pemberton

Professor Chris Pemberton is a Research Professor in the Department of Medicine at the University of Otago, Christchurch, and Director of the Translational Biodiscovery Laboratory within the Christchurch Heart Institute. He earned his BSc and MSc (Hons) from the University of Canterbury and his PhD from the University of Otago. His research centers on cardioendocrinology, encompassing novel protein and peptide biomarker identification and measurement, cardioendocrine signaling in the circulation and heart tissue, ex vivo studies of novel cardiovascular diagnostic and therapeutic agents, and the commercialization of biomedical technologies. Pemberton leads the Translational Biodiscovery Laboratory, which is audited to FDA standards and operates under ISO15189 regulations. The lab develops advanced assays for biomarkers including atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), N-terminal pro-BNP (NT-proBNP), C-type natriuretic peptide (CNP), adrenomedullin, angiotensin II, and signal peptide fragments from preproproteins. It supports commercial studies for international diagnostic companies such as Roche, Abbott, Sphingotec, and ThermoFisher, and conducts in vitro and ex vivo testing for direct cardiac effects of novel agents.